Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M172Revenue (TTM) $M96.7Net Margin (%)-74.1Altman Z-Score-2.3
Enterprise Value $M325EPS (TTM) $-2.5Operating Margin %-72.6Piotroski F-Score1
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-79.2Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %17.5Current Ratio2.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-23.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-133.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.5ROIC % (ttm)-35.2Gross Margin Increase y-yN

Gurus Latest Trades with FLDM

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

FLDM is held by these investors:



FLDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEVIN CAPITAL STRATEGIES, L.P. 2017-10-10Buy95,843$4.57-2.41view
LEVIN CAPITAL STRATEGIES, L.P. 2017-09-12Buy60,000$5.25-15.05view
LEVIN CAPITAL STRATEGIES, L.P. 2017-08-17Buy465$3.6621.86view
LEVIN CAPITAL STRATEGIES, L.P. 2017-08-10Buy4,003,129$3.335.15view
LEVIN CAPITAL STRATEGIES, L.P. 2017-08-09Buy1,549$3.1840.25view
Linthwaite Stephen ChristopherPresident & CEO 2017-08-08Buy45,000$2.6667.67view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2017-08-08Buy50,000$2.7164.58view
COLELLA SAMUEL DDirector 2017-08-08Buy35,895$2.7761.01view
McPhail StevenChief Commercial Officer 2017-08-08Buy20,000$348.67view
JONES EVAN/ FADirector 2017-06-07Sell10,900$4.54-1.76view

Press Releases about FLDM :

Quarterly/Annual Reports about FLDM:

News about FLDM:

Articles On GuruFocus.com
Fluidigm to Report Q3 2017 Financial Results and Host Conference Call Oct 19 2017 
Fluidigm to Unveil High-Parameter Tissue Imaging System Oct 18 2017 
Fluidigm to Participate in Two Upcoming Health Care Conferences in September Aug 28 2017 
Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno S Aug 17 2017 
Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering Aug 10 2017 
Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan Aug 02 2017 
Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diag Jul 27 2017 
Fluidigm to Report Q2 2017 Financial Results and Host Conference Call Jul 20 2017 
Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research Jul 18 2017 
European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinic May 04 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK